Review




Structured Review

Promega pgl2basic plasmid
Pgl2basic Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgl2basic plasmid/product/Promega
Average 90 stars, based on 1 article reviews
pgl2basic plasmid - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

93
Addgene inc ppb ct3g cerp2 nr2f2
Ppb Ct3g Cerp2 Nr2f2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppb ct3g cerp2 nr2f2/product/Addgene inc
Average 93 stars, based on 1 article reviews
ppb ct3g cerp2 nr2f2 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Addgene inc ppb ct3g cerp2 tsc22d3
Ppb Ct3g Cerp2 Tsc22d3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppb ct3g cerp2 tsc22d3/product/Addgene inc
Average 90 stars, based on 1 article reviews
ppb ct3g cerp2 tsc22d3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Promega pgl2basic plasmid
Pgl2basic Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgl2basic plasmid/product/Promega
Average 90 stars, based on 1 article reviews
pgl2basic plasmid - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Addgene inc plasmids 19291
Plasmids 19291, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmids 19291/product/Addgene inc
Average 90 stars, based on 1 article reviews
plasmids 19291 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Addgene inc pgl2 e cad 108 ebox mut luc
(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
Pgl2 E Cad 108 Ebox Mut Luc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgl2 e cad 108 ebox mut luc/product/Addgene inc
Average 90 stars, based on 1 article reviews
pgl2 e cad 108 ebox mut luc - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
Addgene inc paper rrid addgene 192904 dox inducible tf expression pierson smela
(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
Paper Rrid Addgene 192904 Dox Inducible Tf Expression Pierson Smela, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paper rrid addgene 192904 dox inducible tf expression pierson smela/product/Addgene inc
Average 93 stars, based on 1 article reviews
paper rrid addgene 192904 dox inducible tf expression pierson smela - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Addgene inc ppb ct3g cerp2 hoxc9
(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
Ppb Ct3g Cerp2 Hoxc9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppb ct3g cerp2 hoxc9/product/Addgene inc
Average 90 stars, based on 1 article reviews
ppb ct3g cerp2 hoxc9 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
Addgene inc ppb ct3g cerp2 wt1
(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
Ppb Ct3g Cerp2 Wt1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppb ct3g cerp2 wt1/product/Addgene inc
Average 93 stars, based on 1 article reviews
ppb ct3g cerp2 wt1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Addgene inc ppb ct3g cerp2 lhx1
(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
Ppb Ct3g Cerp2 Lhx1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ppb ct3g cerp2 lhx1/product/Addgene inc
Average 93 stars, based on 1 article reviews
ppb ct3g cerp2 lhx1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


(A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108)-WT-Luc) or mutated (E-cad (−108) Ebox Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.

Journal: bioRxiv

Article Title: Autophagy regulates tumor growth and metastasis

doi: 10.1101/2023.10.31.564991

Figure Lengend Snippet: (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108)-WT-Luc) or mutated (E-cad (−108) Ebox Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.

Article Snippet: PGL2 E-cad (108) WT-Luc and PGL2 E-cad (108) Ebox Mut-Luc were kindly provided by Dr. Eric R. Fearon (Addgene plasmids 19291 and 19290)( ).

Techniques: Luciferase, Reporter Assay, Knock-Out, Western Blot, Immunofluorescence, Over Expression

(A) Immunoblotting in A431 cells with or without overexpression of p62 and/or Twist1. (B) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108) WT-Luc) or mutated (E-cad (−108) Mut-Luc) Ebox site in cells as in A. (C) Wound healing assay of cell migration in cells as in A. (D) MTS assay of cells proliferation of cells as in A. (E) Tumor growth from cells as in A. (F) Number of lung tumor nodules per at 14 weeks following injection. (G) Immunoblotting in A375 cells with or without p62 overexpression. (H) Tumor growth from cells as in G. (I) Immunoblotting in A375 cells transfected with or without knockdown of Atg7 or p62. (J) Tumor growth from cells as in I. (K) Immunoblotting in HaCaT cells with or without p62 knockdown and treated with or without EGF/TGF-β)over a time course. (L) qRT-PCR analysis of Twist1 in HaCaT as in K treated with EGF/TGF-β for 48 h. (M) qRT-PCR analysis of p62. Data are shown from three independent experiments (mean±S.D.). n=3. *, P <0.05; compared with WT Con cells (B); #, P <0.05; compared with the WT group (B); *, P <0.05; compared with the Con, A431-p62, and A431-Twist1 groups (E); **, P <0.01; compared with the A431-Twist1 group (F).

Journal: bioRxiv

Article Title: Autophagy regulates tumor growth and metastasis

doi: 10.1101/2023.10.31.564991

Figure Lengend Snippet: (A) Immunoblotting in A431 cells with or without overexpression of p62 and/or Twist1. (B) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108) WT-Luc) or mutated (E-cad (−108) Mut-Luc) Ebox site in cells as in A. (C) Wound healing assay of cell migration in cells as in A. (D) MTS assay of cells proliferation of cells as in A. (E) Tumor growth from cells as in A. (F) Number of lung tumor nodules per at 14 weeks following injection. (G) Immunoblotting in A375 cells with or without p62 overexpression. (H) Tumor growth from cells as in G. (I) Immunoblotting in A375 cells transfected with or without knockdown of Atg7 or p62. (J) Tumor growth from cells as in I. (K) Immunoblotting in HaCaT cells with or without p62 knockdown and treated with or without EGF/TGF-β)over a time course. (L) qRT-PCR analysis of Twist1 in HaCaT as in K treated with EGF/TGF-β for 48 h. (M) qRT-PCR analysis of p62. Data are shown from three independent experiments (mean±S.D.). n=3. *, P <0.05; compared with WT Con cells (B); #, P <0.05; compared with the WT group (B); *, P <0.05; compared with the Con, A431-p62, and A431-Twist1 groups (E); **, P <0.01; compared with the A431-Twist1 group (F).

Article Snippet: PGL2 E-cad (108) WT-Luc and PGL2 E-cad (108) Ebox Mut-Luc were kindly provided by Dr. Eric R. Fearon (Addgene plasmids 19291 and 19290)( ).

Techniques: Western Blot, Over Expression, Luciferase, Reporter Assay, Wound Healing Assay, Migration, MTS Assay, Injection, Transfection, Knockdown, Quantitative RT-PCR